SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: jeffbas who wrote (7850)7/25/1999 11:24:00 PM
From: Michael Burry  Read Replies (2) | Respond to of 78485
 
...that I have a bias against debt gamble types of situations

I do too. I don't think any of my money will go into that situation. But it is the workout of workouts, and if one can understand the situation well enough, I see where there can be a potential value coup. Vencor's recent problems (despite a great market position in their industry) tell me that in health care these days nothing is for sure. But someone else with greater insight might see the opportunity.

Mike



To: jeffbas who wrote (7850)7/28/1999 12:02:00 AM
From: TwoBear  Read Replies (1) | Respond to of 78485
 
If you look further into debt obligations, after the sale to HGR, there is not much debt left to cover. Almost all of sale to HGR for 400+ mil was applied to long term debt. With the sale of NCES, the remaining debt could be satisfied. Secondly, how many times have you trusted S&P's recommendations ?

Scott


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News